Cellectis S.A.
Cellectis S.A. (CMVLF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cmvlf · stock forecast · 10 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $3.47
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $3.63 | ↑ 4.59% |
1-day model range: $3.61–$3.64. Peak: $3.64 (+4.59%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CMVLF · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-08-07 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-08-06 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-04-04 | Citigroup | Maintains | Buy→Buy |
| 2023-03-12 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-01-18 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2022-05-23 | Goldman Sachs | Maintains | Sell→Sell |
| 2022-05-17 | Baird | Upgrade ↑ | Neutral→Outperform |
| 2022-05-12 | Barclays | Maintains | Overweight→Overweight |
| 2022-01-05 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2021-10-07 | Baird | Downgrade ↓ | Outperform→Neutral |
Wall Street analysts have recently issued updated ratings on Cellectis S.A. (CMVLF) stock. Of the recent 19 rating actions, 3 were upgrades and 5 were downgrades. 10 analysts currently cover CMVLF.
Analyst Recommendation Trends
CMVLF analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$60M
↓ 16.8% YoY
Revenue Next Year
$116M
↑ 93.1% YoY
EPS This Year
$-0.91
EPS Next Year
$-0.73
↓ 19.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CMVLF EPS of $-0.91 for the current fiscal year, based on estimates from 1 analysts. The CMVLF revenue forecast is $60M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CMVLF stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CMVLF price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The CMVLF short-term stock prediction for tomorrow is $3.63 (+4.59%).
Cellectis S.A. trades on OTC under the ticker CMVLF. The CMVLF stock outlook for 2027 is broadly positive, supported by a Buy consensus among 70% of covering analysts.
Frequently asked questions
CMVLF forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month CMVLF price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $3.47.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.